Related Experiment Video
Updated: May 16, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Rapalogs in cancer prevention: anti-aging or anticancer?
1Department of Cell Stress Biology; Roswell Park Cancer Institute; Buffalo, NY, USA. blagosklonny@oncotarget.com
Abstract:
Common cancer is an age-related disease. Slow aging is associated with reduced and delayed carcinogenesis. Calorie restriction (CR), the most studied anti-aging intervention, prevents cancer by slowing down the aging process. Evidence is emerging that CR decelerates aging by deactivating MTOR (Target of Rapamycin). Rapamycin and other rapalogs suppress cellular senescence, slow down aging and postpone age-related diseases including cancer. At the same time, rapalogs are approved for certain cancer treatments. Can cancer prevention be explained by direct targeting of cancer cells? Or does rapamycin prevent cancer indirectly through slowing down the aging process? Increasing evidence points to the latter scenario.
Insights
Calorie restriction and rapamycin slow aging and prevent cancer by targeting the MTOR pathway. Evidence suggests rapamycin
Area of Science:
- Gerontology and Cancer Research
- Cellular Aging and Carcinogenesis
Background:
- Cancer is predominantly an age-related disease, with aging processes influencing carcinogenesis.
- Calorie restriction (CR) is a well-established intervention that slows aging and reduces cancer incidence.
- The mechanistic target of rapamycin (MTOR) pathway is implicated in aging and cancer development.
Purpose of the Study:
- To investigate whether cancer prevention by rapamycin and CR is primarily due to direct anti-cancer effects or indirect aging deceleration.
- To explore the role of MTOR pathway inhibition in mediating the anti-aging and anti-cancer effects of CR and rapamycin.
Main Methods:
- Review of existing scientific literature on calorie restriction, rapamycin, MTOR signaling, cellular senescence, aging, and cancer.
- Analysis of evidence supporting direct versus indirect mechanisms of cancer prevention.
Main Results:
- Calorie restriction (CR) and rapamycin decelerate aging, partly by inhibiting the MTOR pathway.
- Rapalogs, including rapamycin, have demonstrated efficacy in suppressing cellular senescence and delaying age-related diseases, including cancer.
- Emerging evidence indicates that rapamycin's cancer-preventive effects are more likely mediated through the deceleration of the aging process rather than direct targeting of cancer cells.
Conclusions:
- The anti-aging effects of calorie restriction and rapamycin, mediated via MTOR inhibition, are key to their cancer-preventive properties.
- Rapamycin's role in cancer treatment may be linked to its ability to slow aging and suppress senescence.
- Future research should focus on understanding the indirect, aging-related mechanisms of cancer prevention by rapamycin.
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Replicative Cell Senescence
Replicative Cell Senescence
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
